The invitation is overdue, registration is closed.

Two-day business partnering event The Future of Pharma: UK & Russia

May
24
Tue 12:00 AM - Wed 11:59 PM
When:
Tue 24 May 2016 12:00 AM - Wed 25 May 2016 11:59 PM (UTC+03:00) Moscow, St. Petersburg
Tags:

Russia’s Skolkovo Foundation and UK Trade & Investment invite you to attend a two-day event focusing on the opportunities in Russia’s fast growing pharmaceutical market.  The event will take place at Skolkovo Innovation Centre - Russia’s leading Science Park - on 24-25 May 2016. Top biopharmaceutical companies, leading biotech associations, contract research & manufacturing organisations from both the UK and Russia will participate.

Registration

 

General Information Partner

 

Agenda:

 

24th May

09:00

Welcome coffee

09:30-09:45 Opening session
  • Jonathan Brenton, Minister Counsellor (Prosperity), British Embassy Moscow
  • Kirill Kaem, Vice-President, CEO of Skolkovo Biomedical Cluster

Session 1. Opportunities for Novel Drug Development in the UK

Moderator: German Inozemtsev, Editor-in-chief of Pharmvestnik

09:45-10:30

“Going Global: The UK's Life Sciences Offer”

  • Jon Mowles, UK BIA, Medicines Manufacturing Industry Partnership (MMIP),  UKTI Life Sciences Organisation
  • Irina Bagriantseva, UKTI Lead Inward Investment Adviser
The presentation will cover the UK’s life sciences environment and also the support available from UKTI to foreign-owned life science companies looking to collaborate and/or locate and grow their life science business within the UK.
10:30-11:00

The Centre for Process Innovation and the National Biologics Manufacturing Centre – Innovation in Biopharmaceutical Manufacture

  • Dr. Lucy Foley, the Centre for Process Innovation and the National Biologics Manufacturing Centre
CPI provides assets and resources to support innovations in the manufacture of biologics. Utilising the National Biologics Manufacturing Centre, CPI combines state of the art facilities with technical expertise. CPI helps to de-risk process development through proof of concept testing to accelerate the commercialisation of new processes and technologies.
11:00-11:05 Q&A
11:05-11:35

Сlinical research in the UK: International success built on national excellence”

  • Dr. Ignazio Di Giovanna, PhD, HFICR, СEO, CCA Clinical Research, Clinical & Contract Research Association (CCRA)

The United Kingdom (UK) has been a leader of scientific and medical advances for many decades. With a population of circa 65 million, the UK offers a ready made research facilities and willing market for successful medicines.

The talk will show how the UK is well placed to offer Russian companies the best possible clinical research solution in Europe.
11:35-11:40 Q&A
11:40-12:10

“Global Drug Development Opportunities: Russian Pharma Perspective”

  • Mikhail Samsonov, Medical Director, R-Pharm 
12:10-13:10

Panel discussion “Novel Drug Development in Russia and UK: leading companies’ experience”

Moderator:

  • Mikhail Samsonov, Medical Director, R-Pharm

Panelists:

  • Svetlana Zavidova, Executive Director of Association of Сlinical Trials Organizations (ACTO)
  • Maxim Kholin, Business Development Director, co-founder at GERO
  • Dr. Yury Rukazenkov, Astra Zeneca, Global Clinical Lead, Oncology
  • Victoria Kosmacheva, MD, MBA, Regional Head for Russia, Middle East & Africa, Global Clinical Sciences and Operations
  • Dr. Ignazio Di Giovanna, PhD, HFICR, СEO, CCA Clinical Research, Clinical & Contract Research Association (CCRA)
  • Alexey Konov, PhD, Partner RBV Capital

13:10-14:00

Lunch

Irina Bagriantseva, UKTI Lead Inward Investment Adviser, will be available during the lunch break provide general information on how to set up a business in the UK.

14:00-14:30

ClinTec Innovative Approach ”

  • Irena Vorlova, Senior Director Central and Eastern Europe, CIS countries, ClinTec International

ClinTec has a wealth of expertise in managing clinical trials in all major therapeutic categories including oncology, rare diseases, neurology, autoimmune diseases and diabetes.

A Masters degree course was innovated in collaboration between Edinburgh Napier University and ClinTec International to support the development of clinical research staff throughout the world, and now endorsed by the ATC. The Masters programme is accessible globally and has an enrolment of students from 14 countries. 

ClinTec offers various courses through its Academy of Clinical Research Excellence (ACRE)

on individual clinical research functions including Clinical Operations, Data Management, Quality Assurance, Biostatistics, Medical Writing and Regulatory Affairs.

Session 2. UK Pharmaceutical Companies in Russia

Moderator: Kristina Khodova, Skolkovo Foundation

14:30-15:00

“What can science do? AstraZeneca as a pioneer in drug development for lung cancer”

  • Dr. Yury Rukazenkov, Astra Zeneca, Global Clinical Lead, Oncology
15:00-15:30

“GSK as the part of Russian Clinical Landscape and Russia in GSK universe”

  • Victoria Kosmacheva, MD, MBA, Regional Head for Russia, Middle East & Africa, Global Clinical Sciences and Operations
15:30 Coffee break
16:00-18:00 Partnering session
18:00 Day 1 Adjournment

 

25th May

10:00 Welcome coffee

Session 3. Opportunities for Novel Drug Development in Russia

10:30-11:30

“Russian Pharma & Biotech Market”

Baker&McKenzie

11:30-12:00

«Current state and development prospects of the local pharmaceuticals market. The view of pharmaceutical manufactures.”

  • Victor Dmitriev, Association of the Russian pharmaceutical manufacturers (ARPM)

12:00-12:30

The Russian Venture Capital Market

  • Pavel Morozov, PhD, Investment Director, RBV Capital
12:30-12:45 Q&A
12:45-13:30 Lunch
13:30-16:00 Partnering sessions
16:00 Seminar Adjournment and Departure

 

Speakers

Jonathan Brenton

Minister Counsellor Prosperity British Embassy Moscow

Kirill Kaem

Vice-President of Skokovo Foundation. Head of Biological and Medical Technology Cluster

John Lindfield

Director of UKTI Russia, UK Trade & Investment

German Inozemtsev

Editor-in-Chief of the research and information paper Pharmaсeutical Newsletter

Jon Mowles

UK BIA, Medicines Manufacturing Industry Partnership (MMIP), UKTI Life Sciences Organisation

Irina Bagriantseva

UKTI Lead Inward Investment Adviser

Dr. Lucy Foley

Centre for Process Innovation and the National Biologics Manufacturing Centre

Dr. Ignazio Di Giovanna, PhD, HFICR

СEO, CCA Clinical Research, Clinical & Contract Research Association (CCRA)

Mikhail Samsonov

Medical Director, R-Pharm

Svetlana Zavidova

Executive Director of Association of Сlinical Trials Organizations (ACTO)

Maxim Kholin

Deputy Director, co-founder at Quantum Pharmaceuticals and Quantum Age, Business Development Director, co-founder at GERO MS Law, MS Finances

Alexey Konov

Partner RBV Capital

Irena Vorlova

Senior Director Central and Eastern Europe, CIS countries, ClinTec International

Dr. Yury Rukazenkov

Astra Zeneca, Global Clinical Lead, Oncology

Victoria Kosmacheva, MD, MBA

Regional Head for Russia, Middle East & Africa, Global Clinical Sciences and Operations

Kristina Khodova, MD, PhD

Head of Oncology/Immunology Projects, Biomedical Cluster, Skolkovo Foundation

Pavel Morozov

Investment Director RBV Capital

Yana Pavlovskaya

Head of Team (Technology, Health, Environment & Agriculture)

Ekaterina Zhuravleva

Trade and Investment Adviser (Healthcare & Medical, Life Sciences) UK Trade & Investment

Viktor Dmitriev

CEO, Association of RussianPharmaceutical Manufacturers

 

This event will help you to into the Russian market that offers:

  • A strong demand for innovative drugs including OTC
  • A growing appetite for European technologies and know-how in pharmaceutical production, particularly in generics.
  • A modern Life Sciences infrastructure and highly qualified workforce
  • A clinical trials market ranked third in the Country Attractiveness Index and worth £600m

 

Networking events

UKTI Russia will organise one-to-ones with top Russian biopharmaceuticals companies during the partnering session. Further networking opportunities will include an evening reception at the UK Ambassador’s Residence in Moscow.

 

Participation fee:

Participation in the event is FREE OF CHARGE, but participants will be responsible for their own travel and hotel expenses

 

Contact:

Ekaterina Zhuravleva,
Trade and Investment Adviser
Тел: +7 (495) 956-74-62
E: Ekaterina.Zhuravleva@fco.gov.uk.

Kristina Khodova,
Skolkovo Foundation
Тел: +7 (495) 956-00-33 (ext. 2522)
E: KKhodova@sk.ru